Tracers / [89Zr]Zr-Df-IgG-800CW
[89Zr]Zr-Df-IgG-800CW
Also written as Df-IgG-800CW; Zr-89 Df-IgG-800CW; Zr-89-Df-IgG-800CW
- Radionuclide
- Zr-89 t½ 4704 min
- Modality
- PET
- Production route
- —
- Stage
- —
- Syntheses indexed
- 0
What it is
- Compound class
- —
- Target / mechanism
- —
- Clinical application
- —
- Theranostic pair
- —
Regulatory status
- FDA
- —
- EMA (centralised)
- —
- Other approvals
- —
- Brand names
- —
Clinical use
- Typical injected activity
- —
- Uptake time
- —
Reported in the literature. Not a dosing recommendation.
Published syntheses
No synthesis has been parsed for this agent yet.
Need this precursor?We can point you to suppliers for [89Zr]Zr-Df-IgG-800CW, or handle the enquiry for you.
Get in touchQuality control Preliminary — inferred from compound class
- Ph. Eur. monograph
- —
- USP monograph
- —
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); radiometal tracer -> metal impurities (rule); receptor ligand with a saturable target -> molar activity (rule)
Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived
Setting up quality control?We can help you scope the equipment needed to release [89Zr]Zr-Df-IgG-800CW.
Get in touchNotes
Added from reverse module search (stage 6); 1 article(s) with Zr-89. Stage 25: this agent has NO own synthesis/characterisation data in the current corpus -- none of the linked articles mention this compound at all -- each is about a different Zr-89/225Ac-labelled antibody conjugate. All previously-linked runs were unlinked (see parsed-therapy.xlsx).